Table 1 Study cohort characteristics

From: Intestinal microbiology and urinary tract infection associated risk in long-term aged care residents

Variable

Aged care residents

Non-elderly

Number of participants, n

123

20

Female sex, n (%)

100 (81.3)

15 (75)

Age (years), median [IQR]

87.6 [81.3–93]

36.5 [24–49.5]

12-month mortality, n (%)

23 (18.7)

0 (0)

Time (days) to mortality, mean ± SD

149 ± 87

0 ± 0

Dementia, n (%)

70 (56.9)

0 (0)

Moderate-severe incontinence, n (%)

112 (91.1)

0 (0)

Number of participants with ≥1 antibiotic dispensed (prior 12 months), n (%)

74 (60.2)

0 (0)

Antibiotics prescribed per participant (prior 12 months), median [IQR]

3 [0-6.5]

0 [0]

Number of participants prescribed UTI-exclusive therapy (prior 12 months)a, n (%)

27 (21.9)

0 (0)

Number of participants prescribed other antibiotics (prior 12 months)b, n (%)

67 (54.5)

0 (0)

UTI incidence in 24-month period, n (%)

54 (43.9)

0 (0)

Urosepsis incidence in 24-month period, n (%)

4 (3.3)

0 (0)

Number of recorded UTIs in 24-month period, n

110

0 (0)

  1. aTrimethoprim, nitrofurantoin and methenamine hippurate.
  2. bAmoxicillin, amoxicillin/clavulanic acid, azithromycin, cefaclor, cefalexin, ceftriaxone, cefuroxime, ciprofloxacin, clarithromycin, clindamycin, doxycycline, erythromycin, flucloxacillin, metronidazole, norfloxacin, roxithromycin, and trimethoprim/sulfamethoxazole.